Parexel International Corporation Overview
Pro stress-test →Parexel International Corporation is a biopharmaceutical services company that provides clinical research, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. For over 35 years Parexel has been a trusted global CRO and biopharmaceutical services company.
Strategic Profile
Pro stress-test →Parexel was recognized for industry-leading clinical development impact, combining regulatory leadership, therapeutic expertise, AI driven innovation and meaningful community leadership that advances biomedical R&D. The company was acquired by EQT (in July 2021) and is positioned as a full-service global CRO with presence in 51 countries.
Competitive Landscape
Pro stress-test →Worldwide Clinical Trials, Syneos Health, CTI Clinical Trial and Consulting, PSI CRO, and Allucent are competitors of Parexel. Parexel competes in the full-service CRO market where competitors offer overlapping clinical research, consulting, and data management services. The market is consolidating with private equity backing becoming common.
Industry Context
Parexel International Corporation operates in Contract Research Organizations (CRO).
Key facts
Founded: 1982 · Headquarters: Raleigh, North Carolina · Employees: 22,000 · Revenue: Estimated $2.3B+ (based on 2017 public filing of $2.3B; private since 2021) · Market cap: N/A